Rafael Holdings, Inc.
A healthcare holding company in Newark, New Jersey, Rafael Holdings backs early-stage drug and medical-device ventures, with its lead therapy Trappsol® Cyclo™ in late-stage trials for the rare Niemann-Pick type C1 disease and the FDA-cleared VECTR System for ligament-release surgery. It was spun off in 2018 from IDT Corporation, the telecom run by Howard Jonas. Its name comes from the Hebrew for "God heals" — fitting for a company built around medicines.
Granted 1.06M · Bought 16.31M · Sold 112.6K
Sold 112.6K
Granted 751.2K
Granted 363.1K
Granted 140.0K
Granted 29.5K
Granted 121.7K
Granted 89.9K
Granted 60.2K
Granted 50.8K
Granted 50.0K
Granted 34.7K
Granted 6.6K
Granted 5.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Jonas Howard SExec Chairman, CEO & President, Director, 10% owner · 31 transactions | — | 14.99M | 1.06M | 16.31M | 112.6K |
| i9 PLUS, LLC10% owner · 3 transactions | — | 3.23Mas of Aug 2022 | — | — | 112.6K |
| Conkling WilliamChief Executive Officer · 15 transactions | — | 564.5Kas of Mar 2025 | 751.2K | — | — |
| Fabbio PatrickCFO & President · 2 transactions | — | 335.2Kas of Dec 2022 | 363.1K | — | — |
| Polinsky DavidChief Financial Officer · 22 transactions | +1561.7% | 299.1K | 140.0K | — | — |
| Sieger MarkusDirector · 2 transactions | — | 219.7K | 29.5K | — | — |
| Weiss Michael JDirector · 4 transactions | +605% | 141.9K | 121.7K | — | — |
| Greenberg Stephen MDirector · 4 transactions | +712.8% | 102.5Kas of Jan 2025 | 89.9K | — | — |
| McCamish Mark AnthonyDirector · 3 transactions | — | 60.2Kas of Jan 2024 | 60.2K | — | — |
| Stein Mark NDirector · 2 transactions | — | 50.8K | 50.8K | — | — |
| Goldberg JohnCHIEF MEDICAL OFFICER · 1 transaction | — | 50.0Kas of Jan 2025 | 50.0K | — | — |
| Pasche Boris CDirector · 2 transactions | +275.1% | 47.3Kas of Jan 2023 | 34.7K | — | — |
| Grayson AlanDirector · 1 transaction | — | 6.6K | 6.6K | — | — |
| Klinger Shannon ThymeDirector · 1 transaction | — | 5.4Kas of Jan 2022 | 5.4K | — | — |
| Mallik AmeetDirector · 1 transaction | -100% | 0as of Feb 2022 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: +16.08M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.